Most advertising these days is predominantly digital and has infiltrated almost every platform we use. Sometimes however, it’s necessary to close the laptop and go out into the real world, but clever marketing minds have moved past the stagnant billboards and one-dimensional print ads of the Mad Men era, blurring the lines between the digital and real worlds.
Digital advertising and media company Motio (ASX: MXO) is a company brimming with these marketing gurus, using place based location intelligence to create memorable brand and customer experiences.
The Company’s tech not only captures audience attention, but uses live analytics and audience insights to provide tangible impacts and return on investment for client companies. Their advertising displays are utilised by numerous industries, promoting “ultra high dwell time” and organic mobile searches.
Expanding their healthcare based offering, MotioHealth, the Company has signed a four year Advertising and Content license agreement with IPN Medical Centres.
IPN are a member of the Sonic Healthcare Group (ASX: SHL) which operates more than 160 medical centres, providing over 10 million patient consultations a year.
Motio will provide 150 fully networked digital displays across various sites over the next 6 months to deliver engaging content for patients at the right time and with relevant intent.
CEO of Motio, Adam Cadwallader welcomed the partnership, commenting: “We have been working with IPN to integrate with its customer experience model and are now ready to roll out across its extensive group of centres. As well as the provision of Health and Information based content, IPN will have direct access to its part of the Motio network to communicate key messaging across the entire group or even down to a single location. The Motio Platform allows IPN to communicate up to the minute health information right through to the marketing of allied services available across the IPN network.”
The first deployment of Motio tech into IPN centres is planned for December 2021, marking the expansion of their MotioHealth division, further adding to the Company’s scale and audience reach in the health and wellbeing sector.
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
- Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
- How this company is developing medtech to support Indigenous community health - August 22, 2022
- A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
Leave a Comment
You must be logged in to post a comment.